Pernicious anemia (PA) subsequent to insulin-dependent diabetes mellitus and idiopathic thrombocytopenic purpura, and effects of oral cobalamin on PA.
Kondo
H
H
Imamura
T
T
D000017:ABO Blood-Group System / Q000032:analysis; D000284:Administration, Oral; D000368:Aged; D000748:Anemia, Macrocytic / Q000209:etiology / Q000276:immunology; D000752:Anemia, Pernicious / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000276:immunology; D005260:Female; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D006879:Hydroxocobalamin / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000276:immunology; D007437:Intrinsic Factor / Q000276:immunology*; D007453:Iodide Peroxidase / Q000276:immunology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000276:immunology; D013954:Thyroglobulin / Q000276:immunology
D000017:ABO Blood-Group System; D001323:Autoantibodies; D007328:Insulin; D007437:Intrinsic Factor; D013954:Thyroglobulin; D007453:Iodide Peroxidase; D005968:Glutamate Decarboxylase; D006879:Hydroxocobalamin